...
Recording: TODO https://drive.google.com/file/d/1LfjgUOcmLmc4LY3Qr-13Qgr7UBxckI-F/view?usp=drive_link
Discussion topics
Item | Presenter | Notes |
---|
Phosphate issue update | AMI | (CB, pre-presentation: group meeting at OpenEye now clashes with this meeting so it’ll be hard for me to make it regularly) CB: is capital K the force constant? CB: is phosphonate O being pulled into -OH? An electrostatic attraction that overwhelms the angle? AMI: yes, they basically all look like that CB: so maybe in the MM the issue is that the electrostatics are dominating, which is not present in the QM wavefunction … CB: So we’re titrating between force constants to prevent the valence angle from being overwhelmed? JR: how well do charges reproduce dipole moment? JR: I don’t like AM1 (and -BCC), especially for P and S. First question is if it gets the dipole moment right CB: if we can understand what’s going on better, maybe it will help us figure out a solution. I’m wondering if the defect has more to do with atom-centered charges and the strong attraction between O and H. For these particular molecules it just happens to be strong enough that it affects the angle unless we set the k artificially high. I see the H-O-P angle is not distorting, just the O-P-O. JR: IMO the charge density here needs to be described using more than just charge. openFF is discussing off-centered charges, which seems reasonable to me, but wondering if we should look at “that” [off-centered charge / multipoles] as final solution CB: if we think we’re going down a singularity caused by the H-O-P-O pattern, I would look at making a bond angle that’s #1-#8:1-#15:2-#8:3. Make an OPO angle specific to HOPO. Replaces good physics with more specific smarts pattern. Leave other parameter to be more general. AMI: think this is a good idea. This is the framework we’re more aligned with.
JR: would this affect how the molecule H-bonds with others?
CB: if you freeze a40 at the MSM value, does that make it low or high? JR: so why are we looking at this neutral version and not the anion? AMI: this is from the industry benchmarking set. CB: a medicinal chemist makes and registers a phosphoric acid, but it ionises once you put it into a buffer or enzyme assay. It wouldn’t occur in biological milieu. Same issue with sulfonic acids.
|
| | CB: want to ask about fitting philosophy. OpenEye is looking into bespoke fitting. I hate it, it admits defeat in the general FF. OpenFF is working to improve a general FF so we need bespoke fitting less. Does OpenFF have a larger strategy for recommending when to use a bespoke FF? Bespoke fitters still want to generalize their parameters, and AMI here is splitting out parameters for more specificity BS: came up recently that we could have a confidence metric for a particular compound that looks at whether it’s represented in the training set. Is a similar tool what you’re after? CB: that’s an end product, at the end of this discussion.
|
Action items
Decisions